NVNO (STOCKS)
enVVeno Medical Corporation Common Stock
$9.300000
-0.050000 (-0.53%)
Prev close: $9.350000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Robert Andrew Berman
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $5.47M
- Employees
- 37
- P/E (TTM)
- -0.24
- P/B (TTM)
- 0.18
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
0
Strong Buy
0
Buy
3
Hold
1
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$-8.05 | $-10.71 | +2.6600 | +24.84% |
|
Jun 2025 (Q2)
|
$-11.55 | $-10.00 | -1.5540 | -15.55% |
|
Mar 2025 (Q1)
|
$-0.22 | $-0.35 | +0.1268 | +36.56% |
|
Dec 2024 (Q4)
|
$-0.30 | $-0.36 | +0.0570 | +15.97% |
Financial Statements
| Nonoperating Income/Loss | $1.62M |
| Selling, General, and Administrative Expenses | $12.04M |
| Depreciation and Amortization | $145.00K |
| Research and Development | $11.55M |
| Operating Income/Loss | -$23.59M |
| Income/Loss From Continuing Operations After Tax | -$21.97M |
| Income/Loss From Continuing Operations Before Tax | -$21.97M |
| Net Income/Loss | -$21.97M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$21.97M |
| Net Income/Loss Available To Common Stockholders, Basic | -$21.97M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$1.08 |
| Diluted Earnings Per Share | -$1.08 |
| Basic Average Shares | 41,586,000 |
| Diluted Average Shares | 21,365,000 |
| Assets | $32.35M |
| Current Assets | $31.50M |
| Noncurrent Assets | $853.00K |
| Fixed Assets | $82.00K |
| Other Non-current Assets | $771.00K |
| Liabilities | $2.91M |
| Current Liabilities | $2.40M |
| Noncurrent Liabilities | $505.00K |
| Equity | $29.45M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $29.45M |
| Liabilities And Equity | $32.35M |
| Net Cash Flow From Operating Activities | -$17.23M |
| Net Cash Flow From Operating Activities, Continuing | -$17.23M |
| Net Cash Flow From Investing Activities | $618.00K |
| Net Cash Flow From Investing Activities, Continuing | $618.00K |
| Net Cash Flow From Financing Activities | $241.00K |
| Net Cash Flow From Financing Activities, Continuing | $241.00K |
| Net Cash Flow | -$16.37M |
| Net Cash Flow, Continuing | -$16.37M |
| Comprehensive Income/Loss | -$21.97M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$21.97M |
| Other Comprehensive Income/Loss | $0.00 |